Effectiveness and durability of mRNA-1273 BA.4/BA.5 bivalent vaccine (mRNA-1273.222) against SARS-CoV-2 BA.4/BA.5 and XBB sublineages.

Autor: Ackerson BK; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA, USA., Bruxvoort KJ; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA, USA.; Department of Epidemiology, University of Alabama at Birmingham, Birmingham, AL, USA., Qian L; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA, USA., Sy LS; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA, USA., Qiu S; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA, USA., Tubert JE; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA, USA., Lee GS; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA, USA., Ku JH; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA, USA., Florea A; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA, USA., Luo Y; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA, USA., Bathala R; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA, USA., Stern J; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA, USA., Choi SK; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA, USA., Takhar HS; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA, USA., Aragones M; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA, USA., Marks MA; Infectious Disease, Epidemiology, Moderna Inc, Cambridge, MA, USA., Anderson EJ; Infectious Disease, Epidemiology, Moderna Inc, Cambridge, MA, USA., Zhou CK; Infectious Disease, Epidemiology, Moderna Inc, Cambridge, MA, USA., Sun T; Infectious Disease, Epidemiology, Moderna Inc, Cambridge, MA, USA., Talarico CA; Infectious Disease, Epidemiology, Moderna Inc, Cambridge, MA, USA.; Epidemiology, AstraZeneca, Gaithersburg, MD, USA., Tseng HF; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA, USA.; Department of Health Systems Science, Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, CA, USA.

Publikováno v: Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2024 Dec 31; Vol. 20 (1), pp. 2335052. Date of Electronic Publication: 2024 Apr 04.

Differences in Estimates of Post-Herpetic Neuralgia Between Medical Chart Review and Self-Report

Autor: Tanenbaum HC, Lawless A, Sy LS, Hong V, Ackerson B, Bruxvoort K, Luo Y, Tseng HF

Publikováno v: Journal of Pain Research, Vol Volume 13, Pp 1757-1762 (2020)

Hilary C Tanenbaum, Anna Lawless, Lina S Sy, Vennis Hong, Bradley Ackerson, Katia Bruxvoort, Yi Luo, Hung Fu Tseng Kaiser Permanente Southern California, Department of Research and Evaluation, Pasadena, CA, USACorrespondence: Hung Fu Tseng Tel +1 626

Externí odkaz: https://doaj.org/article/a1157d6618fd4453b769b91f2c692eb2

Safety of the Seasonal Influenza Vaccine in 2 Successive Pregnancies.

Autor: Getahun D; Department of Research & Evaluation, Kaiser Permanente Southern California, Pasadena.; Department of Health Systems Science, Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, California., Liu IA; Department of Research & Evaluation, Kaiser Permanente Southern California, Pasadena., Sy LS; Department of Research & Evaluation, Kaiser Permanente Southern California, Pasadena., Glanz JM; Institute for Health Research, Kaiser Permanente Colorado, Denver., Zerbo O; Kaiser Permanente Vaccine Study Center, Kaiser Permanente Northern California, Oakland., Vazquez-Benitez G; HealthPartners Institute, Minneapolis, Minnesota., Nelson JC; Kaiser Permanente Washington Health Research Institute, Seattle, Washington., Williams JT; Denver Health Ambulatory Care Services, Denver, Colorado., Hambidge SJ; Denver Health Ambulatory Care Services, Denver, Colorado., McLean HQ; Marshfield Clinic Research Institute, Marshfield, Wisconsin., Irving SA; Kaiser Permanente Center for Health Research, Portland, Oregon., Weintraub ES; Immunization Safety Office, Centers for Disease Control and Prevention, Atlanta, Georgia., Qian L; Department of Research & Evaluation, Kaiser Permanente Southern California, Pasadena.

Publikováno v: JAMA network open [JAMA Netw Open] 2024 Sep 03; Vol. 7 (9), pp. e2434857. Date of Electronic Publication: 2024 Sep 03.

Ischemic Stroke After Bivalent COVID-19 Vaccination: Self-Controlled Case Series Study.

Autor: Xu S; Department of Research & Evaluation, Southern California Permanente Medical Group, Pasadena, CA, United States., Sy LS; Department of Research & Evaluation, Southern California Permanente Medical Group, Pasadena, CA, United States., Hong V; Department of Research & Evaluation, Southern California Permanente Medical Group, Pasadena, CA, United States., Holmquist KJ; Department of Research & Evaluation, Southern California Permanente Medical Group, Pasadena, CA, United States., Qian L; Department of Research & Evaluation, Southern California Permanente Medical Group, Pasadena, CA, United States., Farrington P; School of Mathematics and Statistics, The Open University, United Kingdom., Bruxvoort KJ; Department of Epidemiology, University of Alabama at Birmingham, Birmingham, AL, United States., Klein NP; Kaiser Permanente Vaccine Study Center, Kaiser Permanente Northern California, Oakland, CA, United States., Fireman B; Kaiser Permanente Vaccine Study Center, Kaiser Permanente Northern California, Oakland, CA, United States., Han B; Department of Research & Evaluation, Southern California Permanente Medical Group, Pasadena, CA, United States., Lewin BJ; Department of Research & Evaluation, Southern California Permanente Medical Group, Pasadena, CA, United States.

Publikováno v: JMIR public health and surveillance [JMIR Public Health Surveill] 2024 Jun 25; Vol. 10, pp. e53807. Date of Electronic Publication: 2024 Jun 25.

COVID-19 Vaccination Coverage and Factors Associated With Vaccine Uptake Among People With HIV.

Autor: Hechter RC; Kaiser Permanente Southern California, Pasadena, California.; Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, California., Qian L; Kaiser Permanente Southern California, Pasadena, California., Liu IA; Kaiser Permanente Southern California, Pasadena, California., Sy LS; Kaiser Permanente Southern California, Pasadena, California., Ryan DS; Kaiser Permanente Southern California, Pasadena, California., Xu S; Kaiser Permanente Southern California, Pasadena, California., Williams JTB; Denver Health, Denver, Colorado., Klein NP; Kaiser Permanente Vaccine Study Center, Oakland, California., Kaiser RM; HealthPartners, Bloomington, Minnesota., Liles EG; Kaiser Permanente Center for Health Research, Portland, Oregon., Glanz JM; Institute for Health Research, Kaiser Permanente, Denver, Colorado., Jackson LA; Kaiser Permanente Washington Research Institute, Seattle., Sundaram ME; Marshfield Clinic Research Institute, Marshfield, Wisconsin., Weintraub ES; Centers for Disease Control and Prevention, Atlanta, Georgia., Tseng HF; Kaiser Permanente Southern California, Pasadena, California.; Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, California.

Publikováno v: JAMA network open [JAMA Netw Open] 2024 Jun 03; Vol. 7 (6), pp. e2415220. Date of Electronic Publication: 2024 Jun 03.